Priscilla believes technology innovation in the health sector can significantly improve patient lives. She has multiple years experience in the research, development and translation of technologies to the health sector, including artificial intelligence, medical devices, and pharmaceuticals, both in corporate and start-up settings. As the Director of Upstart Innovations, she currently spends her time as the Vice President of Wintermute Biomedical, which is a biopharmaceutical company developing next-generation antibiotics to combat antimicrobial resistance (AMR).
In addition to this, she is an advisor to DoseMe; a world leading precision dosing software platform. Prior to this, she was leading the Cognitive Health & Life Sciences portfolio at IBM Research - Australia, and co-owner of a medical device company, which was recently acquired. Priscilla’s passion for health and life sciences research began when she undertook a PhD in Engineering at Monash University, specialising in the exploitation of micro and nanoscale phenomena for diagnostic applications.